SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Policy
Report Questions FDA’s Safety Procedures
April 24, 2006
 · 
1 min read
Lone Star Bio
Evidence Of Estrogen And Progesterone Hormone Allergy Has Been Discovered By University of Texas Researchers
April 7, 2006
 · 
1 min read
Lone Star Bio
Antihistamine Use Tied To Brain Tumors
April 5, 2006
 · 
1 min read
Business
ViaGen, Inc. Gallops Into Horse Cloning
March 30, 2006
 · 
5 min read
Lone Star Bio
Evidence Of Estrogen And Progesterone Hormone Allergy Has Been Discovered By Texas Researchers
March 30, 2006
 · 
1 min read
Lone Star Bio
DNA Gene Vaccine Protects Against Harmful Protein Of Alzheimer’s Disease
March 29, 2006
 · 
1 min read
Biotech Bay
Virulent New Strain Of Tuberculosis Sparks Alert
March 24, 2006
 · 
1 min read
Lone Star Bio
Safer Method Found To Treat Heart Failure
March 13, 2006
 · 
1 min read
Lone Star Bio
Worm Hormone Discovery May Aid Fight Against Parasitic Disease
March 9, 2006
 · 
1 min read
Bio NC
Researchers Aim To Regenerate Body Parts
March 9, 2006
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Data Presented at SABCS 2025 Demonstrated that the Endocrine Activity Index® (EAI®) May Identify Patients Most Likely to Benefit from Extended Endocrine Therapy
February 16, 2026
 · 
3 min read
Press Releases
Moleculin Launches CEO Corner Platform to Share Strategic Insights
February 13, 2026
 · 
4 min read
Press Releases
Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
February 13, 2026
 · 
11 min read
Press Releases
Medicenna Announces Changes to Board Composition
February 13, 2026
 · 
6 min read
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
February 12, 2026
 · 
1 min read
Press Releases
Tvardi Therapeutics to Participate in Upcoming Investor Conferences - February 12, 2026
February 12, 2026
 · 
1 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
February 11, 2026
 · 
4 min read
Press Releases
IntraBio Reports Further Detail on Positive Data from Levacetylleucine Pivotal Trial for the Treatment of Ataxia-Telangiectasia
February 11, 2026
 · 
4 min read
Press Releases
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
February 11, 2026
 · 
5 min read
Load More